Amgen stock crashed Tuesday after its highly anticipated weight-loss drug met Wall Street's expectations, but didn't beat ...
Under Secretary for Health Dr. Shereef Elnahal said Monday the VA needs extra funding to cover the costs of drugs such as ...
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...
There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...
America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, ...
For weight loss, you're more likely to have your insurance plan pay for Zepbound, which has the same main ingredient as Mounjaro. The difference is that Mounjaro is for diabetes and Zepbound ...
Currently, only liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound) are approved for weight loss, though some other GLP-1 drugs may be prescribed off-label. Keep in mind that ...
Eli Lilly, maker of Zepbound, sponsored the trial ... more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, a new study shows. Back to top ...